Please assess the completion status of the following clinical trial:

Trial Title: Fatty Acid Ethyl Esters in Meconium of Infants of Diabetic Mothers: a Pilot Trial

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria: (understood to include only abstemious women)~1. . Pregnant women expected to deliver between 37 and 41 weeks gestation (controls), and their babies~2. . Pregnant women expected to deliver between 37 and 41 weeks gestation who have class A1 diabetes mellitus, and their babies~3. . Pregnant women expected to deliver between 37 and 41 weeks gestation who have class A2 diabetes mellitus, and their babies~4. . Pregnant women expected to deliver between 37 and 41 weeks gestation who were diagnosed with diabetes mellitus prior to their pregnancy, and their babies.~Exclusion Criteria:~1. . Mothers who self-reported any alcohol or any illicit drug use during their pregnancy (and their babies)~2. . Mothers who had a positive drug screen at any point during their pregnancy (and their babies)~3. . Babies whose mothers suffered a placental abruption during their pregnancy.~4. . Babies whose mothers had inadequate prenatal care (defined as \<3 prenatal clinic visits prior to admission for delivery)~5. . Non-English-speaking mothers~6. . Babies who pass meconium in utero.~7. . Babies born with multiple congenital anomalies or abdominal wall defects.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Control (Type: None): Pregnant women without either gestational or pre-gestational diabetes mellitus (and their offspring).
- A1 IDM (Type: None): Pregnant women with abnormal glucose tolerance test but normal fasting serum glucose levels (and their offspring).
- A2 IDM (Type: None): Pregnant women with abnormal glucose tolerance test and fasting hyperglycemia (and their offspring).
- PGDM - IDM (Type: None): Pregnant women with diabetes mellitus diagnosed prior to current pregnancy (and their offspring).

Based on this trial design, predict the completion outcome and termination type (if applicable).